Summit Trail Advisors, LLC Unity Biotechnology, Inc. Transaction History

Summit Trail Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $46,026 - $85,592	13,458 New	13,458 $71,000
Q3 2020 Nov 16, 2020	SELL	$2.94 - $12.43 $39,566 - $167,282	-13,458 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.62 - $9.63 $75,633 - $129,600	13,458 New	13,458 $82,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.